Androgens, such as testosterone, play a crucial role in the development of the TMPRSS2-ERG fusion. The TMPRSS2 gene contains androgen-responsive elements, which, upon activation by androgens, drive the expression of the ERG oncogene. This mechanism highlights the significance of androgen signaling in prostate cancer pathogenesis.
